Research Article
Role of miRNA-495 and NRXN-1 and CNTN-1 mRNA Expression and Its Prognostic Importance in Breast Cancer Patients
Table 2
Association of miRNA-495 expression in breast cancer cases with different clinicopathological features.
| Variables | miRNA-495 expression | value | Mean | SD |
| Relative expression | 0.07 | 0.05 | — |
| Age | ≤50 years | 0.09 | 0.11 | 0.02 | >50 years | 0.04 | 0.02 |
| Menopause | Yes | 0.04 | 0.03 | 0.0001 | No | 0.12 | 0.12 |
| Lymph nodes | Yes | 0.07 | 0.10 | 0.21 | No | 0.07 | 0.07 |
| ER status | Yes | 0.05 | 0.04 | 0.10 | No | 0.09 | 0.10 |
| PR status | Yes | 0.05 | 0.05 | 0.11 | No | 0.08 | 0.09 |
| HER2 status | Yes | 0.05 | 0.04 | 0.49 | No | 0.08 | 0.10 |
| TNM stages | Early stage (I & II) | 0.12 | 0.11 | 0.02 | Advanced stage (III & IV) | 0.05 | 0.03 |
| Distant metastases | Yes | 0.04 | 0.02 | 0.27 | No | 0.08 | 0.09 |
|
|